Evaluation of a toolkit to improve cardiovascular disease screening and treatment for people with type 2 diabetes: Protocol for a cluster-randomized pragmatic trial

Trials

Volumn 11, Issue , 2010, Pages

  Shah, Baiju R ^a,b,c   Bhattacharyya, Onil ^a,d   Yu, Catherine ^a,d   Mamdani, Muhammad ^a,b,d   Parsons, Janet A ^a,d   Straus, Sharon E ^a,d   Zwarenstein, Merrick ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c Sunnybrook Health Sciences Centre   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STATIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CARDIOVASCULAR AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; BLOOD PRESSURE; BODY MASS; CANADA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CLUSTER ANALYSIS; EDUCATION; EVIDENCE BASED PRACTICE; GENERAL PRACTITIONER; HUMAN; INFORMATION PROCESSING; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; SAMPLE SIZE; SCREENING TEST; SPRING; WAIST CIRCUMFERENCE; ATTITUDE TO HEALTH; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; GENERAL PRACTICE; HEALTH PERSONNEL ATTITUDE; MASS SCREENING; METHODOLOGY; PREDICTION AND FORECASTING; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; TREATMENT OUTCOME;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATTITUDE OF HEALTH PERSONNEL; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CLUSTER ANALYSIS; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS, TYPE 2; FAMILY PRACTICE; GUIDELINE ADHERENCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MASS SCREENING; ONTARIO; PAMPHLETS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 77952926573     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-11-44     Document Type: Article

References (47)

1. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. The Lancet 2007, 369:750-756.
2. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, McGlynn EA, Ware JE. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA: Journal of the American Medical Association 1989, 262:907-913.
3. Gregg EW, Gu Q, Cheng YJ, Narayan KMV, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 2007, 147:149-155.
4. Dawson KG, Gomes D, Gerstein H, Blanchard JF, Kahler KH. The economic cost of diabetes in Canada, 1998. Diabetes Care 2002, 25:1303-1307. 10.2337/diacare.25.8.1303, 12145225.
5. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The New England Journal of Medicine 1993, 329:977-986. 10.1056/NEJM199309303291401, 8366922, Diabetes Control and Complications Trial Research Group.
6. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998, 317:703-713. 28659, 9732337, UK Prospective Diabetes Study Group.
7. UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet 1998, 352:837-853. UK Prospective Diabetes Study Group.
8. The ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine 2008, 358:2560-2572. 10.1056/NEJMoa0802987, 18539916, The ADVANCE Collaborative Group.
9. Gæde P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. The New England Journal of Medicine 2003, 348:383-393. 10.1056/NEJMoa021778, 12556541.
10. Gæde P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. The New England Journal of Medicine 2008, 358:580-591. 10.1056/NEJMoa0706245, 18256393.
11. Harris SB, Stewart M, Brown JB, Wetmore S, Faulds C, Webster-Bogaert S, Porter S. Type 2 diabetes in family practice: room for improvement. Can Fam Physician 2003, 49:778-785. 2214245, 12836867.
12. Harris SB, Ekoé J-M, Zdanowicz Y, Webster-Bogaert S. Glycemic control and morbidity in the Canadian primary care setting (results of the Diabetes in Canada Evaluation study). Diabetes Res Clin Pract 2005, 70:90-97. 10.1016/j.diabres.2005.03.024, 15890428.
13. Chan BTB, Klomp H, Cascagnette P. Quality of diabetes management in Saskatchewan 2006, Saskatoon: Health Quality Council.
14. Shah BR, Hux JE, Laupacis A, Zinman B, Zwarenstein M. Deficiencies in the quality of diabetes care: comparing specialist with generalist care misses the point. J Gen Intern Med 2007, 22:275-279. 10.1007/s11606-006-0027-x, 1824726,1824726, 17357000.
15. Latosinsky S, Fradette K, Lix L, Hildebrand K, Turner D. Canadian breast cancer guidelines: Have they made a difference?. CMAJ 2007, 176:771-776. 1808531, 17353529.
16. Tu K, Mamdani MM, Tu JV. Hypertension guidelines in elderly patients: is anybody listening?. Am J Med 2002, 113:52-58. 10.1016/S0002-9343(02)01144-0, 12116987.
17. Vernacchio L, Vezina RM, Mitchell AA. Management of acute otitis media by primary care physicians: trends since the release of the 2004 American Academy of Pediatrics/American Academy of Family Physicians Clinical Practice Guideline. Pediatrics 2007, 120:281-287. 10.1542/peds.2006-3601, 17671053.
18. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008, 32:S1-S201. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
19. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, Oxman AD, Moher D, . for the CONSORT and Pragmatic Trials in Healthcare (Practihc) groups Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008, 337:a2390. 10.1136/bmj.a2390, 19001484, for the CONSORT and Pragmatic Trials in Healthcare (Practihc) groups.
20. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA: Journal of the American Medical Association 2003, 290:1624-1632.
21. Jaakkimainen L, Shah BR, Kopp A. Sources of physician care for people with diabetes. Diabetes in Ontario: An ICES Practice Atlas 2003, 9.181-9.192. Toronto: Institute for Clinical Evaluative Sciences, Hux JE, Booth GL, Slaughter PM, Laupacis A.
22. Shah BR, Mamdani M, Kopp A. Drug use in older people with diabetes. Diabetes in Ontario: An ICES Practice Atlas 2003, 3.51-3.76. Toronto: Institute for Clinical Evaluative Sciences, Hux JE, Booth GL, Slaughter PM, Laupacis A.
23. Sirois C, Moisan J, Poirier P, Grégoire JP. Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes. Diabetes Care 2007, 30:1880-1882. 10.2337/dc06-2257, 17384345.
24. Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C. Clinical inertia in response to inadequate glycemic control: Do specialists differ from primary care physicians?. Diabetes Care 2005, 28:600-606. 10.2337/diacare.28.3.600, 15735195.
25. Grimshaw J, Eccles M, Thomas R, MacLennan G, Ramsay C, Fraser C, Vale L. Towards evidence-based quality improvement: evidence (and its limitation) of the effectiveness of guideline dissemination and implementation strategies 1966-1998. J Gen Intern Med 2006, 21:S14-S20. 2557130, 16637955.
26. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research 2000, New York: Oxford University Press.
27. Krein SL, Hofer TP, Kerr EA, Hayward RA. Whom should we profile? Examining diabetes care practice variation among primary care providers, provider groups, and health care facilities. Health Serv Res 2002, 37:1159-1180. 10.1111/1475-6773.01102, 1464024, 12479491.
28. Kuper A, Reeves S, Levinson W. An introduction to reading and appraising qualitative research. BMJ 2008, 337:404-407.
29. Pope C, Mays N. Qualitative research: Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ 1995, 311:42-45. 2550091, 7613329.
30. Charmaz K. Grounded theory: Objectivist and constructivist methods. 2000, 509-535. Thousand Oaks: Sage Publications Inc, Denzin NK, Lincoln YS.
31. Robson C. Real World Research: A Resource for Social Scientists and Practitioner-Researchers 1993, Oxford: Blackwell Publishers Ltd.
32. Madriz E. Focus groups in feminist research. Handbook of Qualitative Research 2000, 835-850. Thousand Oaks: Sage Publications, Inc, Denzin NK, Lincoln YS.
33. Health Communication Unit. Using Focus Groups Workbook, Version 2.0. 2002, Toronto, Centre for Health Promotion, University of Toronto.
34. Ryan GW, Bernard HR. Data management and analysis methods. 2000, 769-802. Thousand Oaks: Sage Publications Inc, Denzin NK, Lincoln YS.
35. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991, 50:179-211.
36. Kvale S. InterViews: an introduction to qualitative research interviewing 1996, Thousand Oaks, CA: Sage Publications.
37. Eakin JM, Mykhalovskiy E. Reframing the evaluation of qualitative health research: reflections on a review of appraisal guidelines in the health sciences. J Eval Clin Pract 2003, 9:187-194. 10.1046/j.1365-2753.2003.00392.x, 12787182.
38. Bryman A. Quantity and Quality in Social Research 1988, London: Routledge.
39. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA: Journal of the American Medical Association 2004, 291:335-342.
40. Vaccaro O, Boemi M, Cavalot F, De Feo P, Miccoli R, Patti L, Rivellese AA, Trovati M, Ardigò D, Zavaroni I. The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. Atherosclerosis 2008, 198:396-402. 10.1016/j.atherosclerosis.2007.10.026, 18093594.
41. Raum E, Lietzau S, Stegmaier C, Brenner H, Rothenbacher D. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany. Pharmacoepidemiol Drug Saf 2008, 17:485-494. 10.1002/pds.1589, 18383562.
42. Wan Q, Harris MF, Jayasinghe UW, Flack J, Georgiou A, Penn DL, Burns JR. Quality of diabetes care and coronary heart disease absolute risk in patients with type 2 diabetes mellitus in Australian general practice. Qual Saf Health Care 2006, 15:131-135. 10.1136/qshc.2005.014845, 2464833, 16585115.
43. Colhoun HM, Dong W, Barakat MT, Mather HM, Poulter NR. The scope for cardiovascular disease risk factor intervention among people with diabetes mellitus in England: a population-based analysis from the Health Surveys for England 1991-94. Diabet Med 1999, 16:35-40. 10.1046/j.1464-5491.1999.00017.x, 10229291.
44. Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, Owens DK. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA: Journal of the American Medical Association 2006, 296:427-440.
45. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, Whitty P, Eccles MP, Matowe L, Shirran L, Wensing M, Dijkstra R, Donaldson C. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004, 8:1-72.
46. Farmer AP, Légaré F, Turcor L, Grimshaw J, Harvey E, McGowan JL, Wolf F. Printed educational materials: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews 2008, CD004398.
47. Zwarenstein M, Hux JE, Kelsall D, Paterson M, Grimshaw J, Davis D, Laupacis A, Evans M, Austin PC, Slaughter PM, Shiller SK, Croxford R, Tu K. The Ontario printed educational message (OPEM) trial to narrow the evidence-practice gap with respect to prescribing practices of general and family physicians: a cluster randomized controlled trial, targeting the care of individuals with diabetes and hypertension in Ontario, Canada. Implement Sci 2007, 2:37. 10.1186/1748-5908-2-37, 2217527, 18039361.